A Prospective Pilot Study to Evaluate Safety and Effectiveness of GP0122 and GP0124 for Correction of Lines and Wrinkles in the Cheek Area
Starting soon · Not applicable
Conditions studied: Wrinkle Reduction
In brief
The primary objective of the study is to evaluate the safety of GP0122 and GP0124 for the correction of lines and wrinkles in the cheek area.
Key facts
- Study ID
- NCT07344584
- Run by
- Galderma R&D
- People needed
- 60
- Starts
- 2026-01-16
- Expected to finish
- 2027-06-30
- Last updated by the study team
- 2026-01-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may not qualify if…
- Known/previous allergy or hypersensitivity.
- Known/previous allergy or hypersensitivity to local anesthetics.
- Previous facial surgery (e.g., facelift) in the treatment area that in the Treating Investigator´s opinion.
- Any previous aesthetic procedures or implants in the treatment area.
- Presence of any disease or lesions in the treatment area.
- An underlying known disease, a surgical or medical condition that would expose the participant to undue risk.
- Use of concomitant medication that have the potential to prolong bleeding times.
- Presence of any condition or situation, which in the opinion of the Treating Investigator makes the subject unable to complete the study per protocol.
- Women who are pregnant or breast feeding, or women of childbearing potential who are not practicing adequate contraception or planning to become pregnant during the study period.
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.